BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choonara I. WHO wants safer medicines for children. Arch Dis Child. 2008;93:456-457. [PMID: 18495908 DOI: 10.1136/adc.2007.132563] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 van Riet-Nales DA, Ferreira JA, Schobben AF, de Neef BJ, Egberts TC, Rademaker CM. Methods of administering oral formulations and child acceptability. Int J Pharm 2015;491:261-7. [PMID: 26143234 DOI: 10.1016/j.ijpharm.2015.06.047] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
3 Allegaert K. Neonates need tailored drug formulations. World J Clin Pediatr 2013;2:1-5. [PMID: 25254168 DOI: 10.5409/wjcp.v2.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dixon BJ, Reis C, Ho WM, Tang J, Zhang JH. Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci 2015;16:22368-401. [PMID: 26389893 DOI: 10.3390/ijms160922368] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 14.2] [Reference Citation Analysis]